Speaker Series: Bespoke Checks - An Update on Immune Checkpoint Inhibitors for Cancer Therapy

This publication is a summary of presentations given by Professors Daniel Speiser (Switzerland), Cassian Yee (Texas) and Steven O’Day (Los Angeles) at a dinner symposium held on 2nd December 2014 during the Clinical Oncology Society of Australia (COSA) 41st Annual Scientific Meeting (2-4 December 2014, Melbourne). The presentations covered the biological basics of targeting inhibitory receptors, preclinical and clinical studies of checkpoint inhibitors in the treatment of melanoma, critical patient considerations, and next generation approaches in immune therapy.

Please login below to download this issue (PDF)

Subscribe